Tiny implants to monitor bodily functions or to provide insulin or other drugs based on immediate need would be an advancement in personalized medicine. But a problem inherent in implants is the tendency of the human immune system to recognize the device as an invader and encapsulate it, preventing the device from doing its job.

In the printed circuit board (PCB) industry, manufacturers must drive change or they don’t survive.